Desmoid-type fibromatosis and pregnancy: A multi-institutional analysis of recurrence and obstetric risk

Annals of Surgery

Volumn 259, Issue 5, 2014, Pages 973-978

  Fiore, Marco ^a   Coppola, Sara ^b   Cannell, Amanda J ^c   Colombo, Chiara ^a   Bertagnolli, Monica M ^d   George, Suzanne ^d   Le Cesne, Axel ^b   Gladdy, Rebecca A ^c   Casali, Paolo G ^a   Swallow, Carol J ^c   Gronchi, Alessandro ^a   Bonvalot, Sylvie ^b   Raut, Chandrajit P ^d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY OF TORONTO   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

aggressive fibromatosis; desmoid type fibromatosis; pregnancy; prognosis; wait and see

Indexed keywords

ANTIESTROGEN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT;

ABDOMINAL FIBROMATOSIS; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CESAREAN SECTION; CONTROLLED STUDY; DESMOID TYPE FIBROMATOSIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; INCISIONAL HERNIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR LOCALIZATION; VAGINAL DELIVERY; WATCHFUL WAITING;

ADOLESCENT; ADULT; DELIVERY, OBSTETRIC; FEMALE; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84896876891     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000224     Document Type: Article

References (26)

1. Fibromatoses. In: Weiss SW, Goldblum JR, eds. Enzinger & Weiss' Soft Tissue Tumors. Philadelphia, PA: Mosby Elsevier; 2008: 227-253.
2. Goldblum JR, Fletcher JA. Desmoid-type fibromatosis. In: Fletcher CDM, Krishnan Unni K and Mertens F, eds. WHO Pathology & Genetics, Tumors of Soft Tissue and Bone. IARC Press; 2002: 83-84.
3. Merchant NB, Lewis JJ, Woodruff JM, et al. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer. 1999; 86: 2045-2052.
4. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003; 21: 1390-1397.
5. Fiore M, Rimareix F, Mariani L, et al. Desmoid-type fibromatosis: a frontline conservative approach to select patients for surgical treatment. Ann Surg. Oncol. 2009; 16: 2587-2593.
6. Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg. Oncol. 2008; 34: 462-468.
7. Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progressionfree survival determined from a series of sporadic desmoid tumors: a waitand- see policy according to tumor presentation. J Clin Oncol. 2011; 29: 3553-3558.
8. Bonvalot S, Desai A, Coppola S, et al. The treatment of desmoid tumors: a stepwise clinical approach. Ann Oncol. 2012; 23(suppl 10): x158-x166.
9. Reitamo JJ, Scheinin TM, Hayry P. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg. 1986; 151: 230-237.
10. de Bree E, Keus R, Melissas J, et al. Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther. 2009; 9: 525-535.
11. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
12. Hong H, Nadesan P, Poon R, et al. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). Br J Cancer. 2011; 104: 1452-1458.
13. Ishizuka M, Hatori M, Dohi O, et al. Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med. 2006; 210: 189-198.
14. Santos G, Cunha IW, Rocha RM, et al. Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options. BioSci Trends. 2010; 4: 25-30.
15. Halevy A, Samuk I, Halpern Z, et al. Mifepristone (RU486), a pure antiprogesterone drug, in combination with vinblastine for the treatment of progesterone receptor-positive desmoid tumor. Tech Coloproctol. 2010; 14: 265-267.
16. Picariello L, Tonelli F, Brandi ML. Selective oestrogens receptors modulators in desmoid tumours. Expert Opin Investig Drugs. 2004; 13: 1457-1468.
17. Church JM, McGannon E. Prior pregnancy ameliorates the course of intraabdominal desmoid tumors in patients with familial adenomatous polyposis. Dis Colon Rectum. 2000; 43: 445-450.
18. Stojadinovic A, Hoos A, KarpoffHM, et al. Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg. 2001; 136: 70-79.
19. Carneiro C, Hurtubis C, Singh M, et al. Desmoid tumors of the right rectus abdominus muscle in postpartum women. Arch Gynecol Obstet. 2009; 279: 869-873.
20. Dalen BP, Geijer M, Kvist H, et al. Clinical and imaging observations of desmoid tumors left without treatment. Acta Orthop. 2006; 77: 932-937.
21. Enzinger FM, Shiraki M. Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid). Analysis of thirty cases followed up for ten or more years. Cancer. 1967; 20: 1131-1140.
22. McDougall A, McGarrity G. Extra-abdominal desmoid tumours. J Bone Joint Surg. Br. 1979; 61-B: 373-377.
23. Vandevenne JE, De Schepper AM, De Beuckeleer L, et al. New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol. 1997; 7: 1013-1019.
24. Johner A, Tiwari P, Zetler P, et al. Abdominal wall desmoid tumors associated with pregnancy: current concepts. Expert Rev Anticancer Ther. 2009; 9: 1675-1682.
25. Way JC, Culham BA. Desmoid tumour. The risk of recurrent or new disease with subsequent pregnancy: a case report. Can J Surg. 1999; 42: 51-54.
26. Colombo C, Gronchi A. Desmoid-type fibromatosis: what works best? Eur J Cancer. 2009; 45(suppl 1): 466-467.